FRI0051 Decrease of disease activity and disability and improvement of quality of life in patients with refractory long-standing rheumatoid arthritis treated with monoclonal anti-tumour necrosis factor-alpha antibody
2001 ◽
2013 ◽
Vol 17
(12)
◽
pp. 1590-1595
◽
2016 ◽
Vol 10
(suppl 1)
◽
pp. S58.1-S58
2011 ◽
Vol 24
(1)
◽
pp. 269-274
◽
2015 ◽
Vol 22
(Suppl 1)
◽
pp. A62.1-A62
2006 ◽
Vol 26
(12)
◽
pp. 1125-1131
◽